Log in to save to my catalogue

Blood biomarkers for Alzheimer's disease in clinical practice and trials

Blood biomarkers for Alzheimer's disease in clinical practice and trials

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2816762174

Blood biomarkers for Alzheimer's disease in clinical practice and trials

About this item

Full title

Blood biomarkers for Alzheimer's disease in clinical practice and trials

Publisher

United States: Nature Publishing Group

Journal title

Nature aging, 2023-05, Vol.3 (5), p.506-519

Language

English

Formats

Publication information

Publisher

United States: Nature Publishing Group

More information

Scope and Contents

Contents

Blood-based biomarkers hold great promise to revolutionize the diagnostic and prognostic work-up of Alzheimer's disease (AD) in clinical practice. This is very timely, considering the recent development of anti-amyloid-β (Aβ) immunotherapies. Several assays for measuring phosphorylated tau (p-tau) in plasma exhibit high diagnostic accuracy in disti...

Alternative Titles

Full title

Blood biomarkers for Alzheimer's disease in clinical practice and trials

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2816762174

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2816762174

Other Identifiers

ISSN

2662-8465

E-ISSN

2662-8465

DOI

10.1038/s43587-023-00403-3

How to access this item